Background: Point of care testing for C-reactive protein (CRP) has shown promise as a measure to reduce unnecessary antibiotic prescribing in respiratory tract infections (RTI), but its use in primary ...

The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a study published in ...

Antibiotic prescribing in primary care practice for patients with COPD exacerbations is generally based on clinical features only, which are subjective and suboptimal for identifying patients who will ...

Nov. 15 -- A new blood test that is said to predict heart attack risk better than the cholesterol test has generated a lot of excitement among heart specialists and speculation in news reports that it ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Patients hospitalized with COVID-19 who have high levels of inflammation may benefit significantly ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global C-reactive protein test market since 2018 and the market is poised to grow by USD 110.41 million during 2019-2023, progressing at a ...

A new blood test that may be a better predictor of heart disease and stroke than cholesterol measures catapulted into the headlines recently after a study in the New England Journal of Medicine. The ...

New York, March 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type, By Detection ...

DUBLIN, March 11, 2020 /PRNewswire/ -- The "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report by Assay Type, by Detection Range, by Disease Area (Cancer, Endometriosis, ...

DUBLIN--(BUSINESS WIRE)--The "C-reactive Protein Testing Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The major factors propelling ...

While cholesterol levels are commonly used to assess heart disease risk, research shows that another blood marker—high-sensitivity C-reactive protein (hs-CRP)—may offer even more powerful insight, ...